Abstract
The French Association for Neonatal Screening was created in 1975 in response to the need for an organization to coordinate neonatal screening activities in France. The program of ‘systematic’ neonatal screening has been voluntarily limited to the screening of phenylketonuria and congenital hypothyroidism, and is based on regional delegations. Although screening has not been legally mandated, the percentage of coverage has been very high (99.7%), with 17 million newborns screened for phenylketonuria and 10 million screened for congenital hypothyroidism. The organization also includes regional centralization for follow-up which provides data for evaluation of all aspects of the program.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
